See also this year's filing and all EDGAR filings for this company.
PDF Report 0001367644_2023_Emergent_Biosolutions_Inc.pdf
Logs
| warning | Large missing amount for aggregate "Revenues" added to remainder. | industry.us_generic | {'missing_ratio': 227.75510204081633, 'aggregate_val': 1120900000, 'exp_sum': 4900000, 'exp_to_value': {'remainder_Revenues': 4900000}} |
| warning | Large missing amount for aggregate "Revenues" added to remainder. | industry.us_generic | {'missing_ratio': 183.08771929824562, 'aggregate_val': 1049300000, 'exp_sum': 5700000, 'exp_to_value': {'remainder_Revenues': 5700000}} |
Graph
Absolute values for 0001367644, Emergent Biosolutions Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 1,210,700,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 947,000,000 |
| 2 | PropertyPlantAndEquipmentNet | 817,600,000 |
| 3 | remainder_Assets | 191,300,000 |
| 4 | LiabilitiesCurrent | 1,229,900,000 |
| 5 | LiabilitiesNoncurrent | 481,900,000 |
| 6 | remainder_Liabilities | 71,800,000 |
| 7 | CostOfGoodsAndServicesSold | 293,624,461 |
| 8 | SellingGeneralAndAdministrativeExpense | 337,935,165 |
| 9 | ResearchAndDevelopmentExpense | 191,865,080 |
| 10 | remainder_Expenses | 783,317,444 |
| 11 | remainder_Revenues | 822,116,179 |
| 12 | remainder_NetIncome | -51,065,873 |
| 13 | remainder_ComprehensiveNetIncome | 17,272,374 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 3,166,600,000 |
| 1 | Liabilities | 1,783,600,000 |
| 2 | Expenses | 1,606,742,150 |
| 3 | Revenues | 822,116,179 |
| 4 | StockholdersEquity | 1,383,000,000 |
| 5 | NetIncome | -835,691,844 |
| 6 | ComprehensiveNetIncome | -827,055,657 |
| 7 | BaseVar | 3,723,698,288 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.884 |
| 9 | EconomicCapitalRatio | 2.21 |
Edgar->Model Mapping
Feature Distribution
Change over Time
